抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
CH5424802，98% | C30H34N4O2 | |||
|
|
|||||
|
CEP-33779，99% | C24H26N6O2S | |||
|
|
|||||
|
CH5183284，99% | C20H16N6O | |||
|
|
|||||
|
S49076，98% | C22H22N4O4S | |||
|
|
|||||
|
BMS 911543，≥98% | C23H28N8O | |||
|
|
|||||
|
Verteporfin，97%(HPLC) | C41H42N4O8 | |||
|
|
|||||
|
Erdafitinib，99% | C25H30N6O2 | |||
|
|
|||||
|
ONO-4059 (analog)，≥98% | C25H24N6O3 | |||
|
|
|||||
|
EW-7197，99% | C22H18FN7 | |||
|
|
|||||
|
Olmutinib，99% | C26H26N6O2S | |||
|
|
|||||
|
AZD3463，98% | C24H25ClN6O | |||
|
|
|||||
|
ON123300，≥98% | C24H27N7O | |||
|
|
|||||
|
CNX-2006，≥98% | C26H27F4N7O2 | |||
|
|
|||||
|
LDK378 (dihydrochloride)，≥98% | C28H38Cl3N5O3S | |||
|
|
|||||
|
AD80，99% | C22H19F4N7O | |||
|
|
|||||
|
AMG 925，≥98% | C26H29N7O2 | |||
|
|
|||||
|
Crizotinib (hydrochloride)，≥98% | C21H23Cl3FN5O | |||
|
|
|||||
|
Acalabrutinib(ACP-196)，98% | C26H23N7O2 | |||
|
|
|||||
|
WS3，98% | C28H30F3N7O3 | |||
|
|
|||||
